Małgorzata Lelonek

Medical University of Lodz — Poland

Medicine · Health Sciences

26h-index7.6kcitations225works49.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heart Failure Treatment and Management(59), Cardiovascular Function and Risk Factors(46), Cardiovascular Syncope and Autonomic Disorders(29), Cardiac pacing and defibrillation studies(23), Diabetes Treatment and Management(22)

Publications213 total

One-year prognosis according to BMI among heart failure patients with preserved and mildly reduced ejection fraction in Polish cohort - insights from HF-POL registry
European Heart Journal·2025Open Access
Heart failure in Poland: a 20-year epidemiological perspective
European Heart Journal·2025
The differences between ambulatory and hospitalized heart failure patients who have mildly reduced or preserved ejection fractions: Lessons learned from the HF-POL study
Cardiology Journal·2025Open Access
Importance of an online educational platform for heart failure nurses in Poland: the results of the survey
Cardiology Journal·2025Open Access
Heart Failure in Poland: A 20-Year Epidemiological Perspective
Medicina·2025Open Access
Clinical pathways of patients with heart failure with preserved ejection fraction hospitalized for acute heart failure: Insights from the National Multi-Centre HF-POL Registry
Kardiologia Polska·2024Open Access
Report on heart failure in Poland: data from 2014-2021
2024Open Access
Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
European Journal of Heart Failure·2024· 34 citedOpen Access
Inflammation in Obesity-Related HFpEF
Journal of the American College of Cardiology·2024· 64 citedOpen Access
Cardiovascular risk factors and cardiovascular diseases in patients with most common newly diagnosed cancers in Poland. Preliminary data from the CONNECT-POL registry
Kardiologia Polska·2024Open Access
Semaglutide and NT-proBNP in Obesity-Related HFpEF
Journal of the American College of Cardiology·2024· 69 citedOpen Access
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
The Lancet·2024· 279 citedOpen Access
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
New England Journal of Medicine·2024· 522 citedOpen Access
Baseline characteristics of Polish patients with heart failure with ejection fraction >40%: Results of HF-POL, the first study of the Heart Failure Association
Kardiologia Polska·2024· 1 citedOpen Access
Wyzwania Kardioonkologii – Przypadek Pacjenta z Rakiem Języka i Niewydolnością Serca de novo
Folia Cardiologica·2024Open Access
Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac Society
Kardiologia Polska·2024· 2 citedOpen Access
Egzamin z kardiologii. Tom 1
2024
Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study
Circulation Heart Failure·2024· 69 citedOpen Access
Quality of life in heart failure: New data, new drugs and devices
Cardiology Journal·2023· 5 citedOpen Access
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction
Journal of the American College of Cardiology·2023· 69 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Tadeusz Pietrucha(11), Sanjiv J. Shah(10), Mikhail Kosiborod(7), Barry A. Borlaug(7), Melanie J. Davies(7), Dalane W. Kitzman(7), Michele Senni(7), Mark C. Petrie(7), Aldo P. Maggioni(6), Subodh Verma(6), Vijay Chopra(6), Justin A. Ezekowitz(6), Michael Fu(6), Hiroshi Ito(6), Vojtěch Melenovský(6), Julio Núñez(6), Eduardo Perna(6), Dirk von Lewinski(6), Dennis Wolf(6), Jan Henryk Goch(6)